Exploration of Neuroprotective Therapy

Open Access Review

Blocking cholesterol storage to treat Alzheimer’s disease

Ta Yuan Chang ... James G. Gow

Published: December 30, 2021 Explor Neuroprot Ther. 2021;1:173–184

DOI: https://doi.org/10.37349/ent.2021.00014

This article belongs to the special issue Cholesterol Dyshomeostasis in Neurological Diseases

Full Text PDF

5170 112 19

Open Access Review

Targeting cytochrome P450 46A1 and brain cholesterol 24-hydroxylation to treat neurodegenerative diseases

Irina A. Pikuleva

Published: December 30, 2021 Explor Neuroprot Ther. 2021;1:159–172

DOI: https://doi.org/10.37349/ent.2021.00013

This article belongs to the special issue Cholesterol Dyshomeostasis in Neurological Diseases

Full Text PDF

3979 100 4

Open Access Review

Advancing diagnosis and treatment of Niemann-Pick C disease through biomarker discovery

Xuntian Jiang, Daniel S. Ory

Published: December 30, 2021 Explor Neuroprot Ther. 2021;1:146–158

DOI: https://doi.org/10.37349/ent.2021.00012

This article belongs to the special issue Cholesterol Dyshomeostasis in Neurological Diseases

Full Text PDF

4474 103 17

Open Access Review

Peroxisomes in intracellular cholesterol transport: from basic physiology to brain pathology

Jian Xiao ... Jie Luo

Published: December 30, 2021 Explor Neuroprot Ther. 2021;1:127–145

DOI: https://doi.org/10.37349/ent.2021.00011

This article belongs to the special issue Cholesterol Dyshomeostasis in Neurological Diseases

Full Text PDF

5974 157 3

Open Access Perspective

Maternal imprinting, mitochondrial DNA, nuclear DNA and Alzheimer’s disease

Alberto Pérez-Mediavilla, Marta Zamarbide

Published: October 29, 2021 Explor Neuroprot Ther. 2021;1:121–126

DOI: https://doi.org/10.37349/ent.2021.00010

Full Text PDF

2301 41 0

Open Access Review

Immunization with neural-derived peptides as a neuroprotective therapy for spinal cord injury

Andrea Paola Ibarra-García, Antonio Ibarra

Published: October 29, 2021 Explor Neuroprot Ther. 2021;1:111–120

DOI: https://doi.org/10.37349/ent.2021.00009

Full Text PDF

2708 53 0

Open Access Review

Striking a balance: PIP₂ and PIP₃ signaling in neuronal health and disease

Kamran Tariq, Bryan W. Luikart

Published: October 29, 2021 Explor Neuroprot Ther. 2021;1:86–110

DOI: https://doi.org/10.37349/ent.2021.00008

This article belongs to the special issue Cholesterol Dyshomeostasis in Neurological Diseases

Full Text PDF

11479 341 34

Open Access Review

T-cell based immunotherapies for Parkinson’s disease

Rodrigo Pacheco

Published: October 29, 2021 Explor Neuroprot Ther. 2021;1:72–85

DOI: https://doi.org/10.37349/ent.2021.00007

Full Text PDF

5008 156 8

Open Access Review

Therapeutic potential of the cannabinoid receptor 2 in neuropsychiatry

María S. García-Gutiérrez ... Jorge Manzanares

Published: August 05, 2021 Explor Neuroprot Ther. 2021;1:55–71

DOI: https://doi.org/10.37349/ent.2021.00006

Full Text PDF

6287 221 3

Open Access Review

Gut microbial imbalance and neurodegenerative proteinopathies: from molecular mechanisms to prospects of clinical applications

Paula Alonso-García ... Eva Martínez-Pinilla

Published: August 05, 2021 Explor Neuroprot Ther. 2021;1:33–54

DOI: https://doi.org/10.37349/ent.2021.00005

Full Text PDF

4047 110 0

Open Access Review

Neurological complications during HIV infection

Jose M. Martinez-Navio

Published: August 05, 2021 Explor Neuroprot Ther. 2021;1:19–32

DOI: https://doi.org/10.37349/ent.2021.00004

Full Text PDF

8624 285 1

Open Access Review

Cholesterol in autism spectrum disorders

Rafael Franco ... Irene Reyes-Resina

Published: August 05, 2021 Explor Neuroprot Ther. 2021;1:10–18

DOI: https://doi.org/10.37349/ent.2021.00003

This article belongs to the special issue Cholesterol Dyshomeostasis in Neurological Diseases

Full Text PDF

6206 118 0

Open Access Letter to the Editor

P2X7 receptor involvement in COVID-19 disease

Peter Illes

Published: August 05, 2021 Explor Neuroprot Ther. 2021;1:7–9

DOI: https://doi.org/10.37349/ent.2021.00002

Full Text PDF

2078 44 1

Open Access Editorial

Science plus technology to address challenges in determining the efficacy of neuroprotective/neurorestorative therapies

Rafael Franco

Published: August 05, 2021 Explor Neuroprot Ther. 2021;1:1–6

DOI: https://doi.org/10.37349/ent.2021.00001

Full Text PDF

2646 35 1